⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL371080 | 1.00 | — | — | |
| SCHEMBL16401001 | 1.00 | — | — | |
| SCHEMBL7817503 | 1.00 | — | — | |
| SCHEMBL22487773 | 0.79 | — | — | |
| SCHEMBL8532287 | 0.79 | — | — | |
| SCHEMBL27473589 | 0.79 | — | — | |
| SCHEMBL23534487 | 0.78 | CYP2C19 (0.36) | — | |
| SCHEMBL18630250 | 0.77 | CYP2C19 (0.31) | — | |
| SCHEMBL6765110 | 0.76 | — | — | |
| SCHEMBL5165964 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016943-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2024-01-18 | — | — | US | claimed |
| EP-4251642-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | The University of Chicago (US) | 2023-10-04 | — | — | EP | claimed |
| WO-2022115595-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2022-06-02 | — | — | WO | claimed |
| WO-2018112226-A1 | SHARPIN-BASED POLYPEPTIDES AND THEIR USES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-06-21 | — | — | WO | claimed |
| EP-4399220-A1 | ANTIVIRAL STRUCTURALLY-STAPLED SARS-COV-2 PEPTIDE- CHOLESTEROL CONJUGATES AND USES THEREOF | Dana-Farber Cancer Institute, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240124529-A1 | ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | 2024-04-18 | — | — | US | disclosed |
| US-20240083943-A1 | VEGF-REGULATING PEPTIDES | IDP DISCOVERY PHARMA, S.L. (ES) | 2024-03-14 | — | — | US | disclosed |
| US-20240016943-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2024-01-18 | — | — | US | disclosed |
| US-20240002450-A1 | ANTIVIRAL STRUCTURALLY-STABILIZED EBOLAVIRUS PEPTIDES AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2024-01-04 | — | — | US | disclosed |
| WO-2023215784-A1 | EBOLAVIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| EP-3280431-B1 | DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS | UNIV GEORGIA (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-4271480-A1 | VEGF-REGULATING PEPTIDES | IDP Discovery Pharma, S.L. (ES) | 2023-11-08 | — | — | EP | disclosed |
| WO-2016164768-A1 | DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2016-10-13 | — | — | WO | disclosed |
| US-9302980-B2 | Process for producing solid amino acid | KANEKA CORPORATION (JP) | 2016-04-05 | — | — | US | disclosed |
| WO-2015010048-A1 | CHEMICALLY-STABILIZED A KINASE ANCHORING PROTEIN (AKAP) PEPTIDE DISRUPTORS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2015-01-22 | — | — | WO | disclosed |
| EP-2810933-A1 | METHOD FOR PRODUCING SOLID AMINO ACID | Kaneka Corporation (JP) | 2014-12-10 | — | — | EP | disclosed |
| US-20140343289-A1 | PROCESS FOR PRODUCING SOLID AMINO ACID | KANEKA CORPORATION (JP) | 2014-11-20 | — | — | US | disclosed |
| WO-2012009709-A1 | HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS | PAUL SUDHIR (US) | 2012-01-19 | — | — | WO | disclosed |
| EP-1102757-A1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000008002-A1 | SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2000-02-17 | — | — | WO | disclosed |